Wednesday, November 4, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Semaglutide, Tirzepatide and Clinically Recorded Alcohol-Related Outcomes in Type 2 Diabetes: A Target Trial Emulation

Diabetes, obesity & metabolism · 2026 Nov 3 · Tang H, Zhang B, Lu Y et

MH
By Maren Holt · Senior Reporter, GLP-1
Nov 2 19:00 ETSource: Diabetes, obesity & metabolism

From the source

Semaglutide, Tirzepatide and Clinically Recorded Alcohol-Related Outcomes in Type 2 Diabetes: A Target Trial Emulation

Diabetes, obesity & metabolism · 2026 Nov 3 · Tang H, Zhang B, Lu Y et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →